alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
No: III-23-018 July 5, 2023

Contact: Viktoria Mitlyng, 630-829-9662

 Prema Chandrathil, 630-829-9663

NRC to Conduct Open House to Discuss 2022 

Performance of Point Beach Nuclear Plant

Nuclear Regulatory Commission staff will be available to discuss the 2022 safety performance of the 

Point Beach nuclear power plant during an in-person open house, scheduled for July 10. The two-unit 

facility, operated by NextEra Energy Point Beach, is located in Two Rivers, Wisconsin.

The open house will be held from 5:30-6:30 p.m. Central time at the Two Rivers Fire Department,

2122 Monroe St. in Two Rivers. NRC staff responsible for plant inspection and oversight, including the 

resident inspectors based full-time at the site, will participate in the discussion.

The NRC determined that Point Beach operated safely during 2022. All inspection findings and 

performance indicators were “green,” or of very low safety significance. As a result, Point Beach remains 

under the NRC’s baseline level of oversight, which entails thousands of hours of inspection each year.

The NRC Reactor Oversight Process uses color-coded inspection findings and indicators to measure 

plant performance. The colors start at green and increase to white, yellow or red, commensurate with the 

safety significance of the issues involved. Inspection findings or performance indicators with more than very 

low safety significance trigger increased NRC oversight.

Plant inspections are performed by two NRC resident inspectors and other specialist inspectors from 

the agency’s Region III office in Lisle, Illinois, and NRC headquarters in Rockville, Maryland.

The annual assessment letter for Point Beach is available on the NRC website. Current performance 

information is also available on NRC’s website and updated quarterly.
Exhibit 32.1

 

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the Annual Report of TransAlta Corporation (the “Company”) on Form 40-F/A for the year ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dawn L. Farrell, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 
| 1.     | The Report fully complies with the requirements of   Section 13(a) or 15(d), as applicable, of the Securities Exchange   Act of 1934, as amended; and |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                            |
| 2.     | The information contained in the Report fairly presents, in all   materials respects, the financial condition and result of operations of the   Company.        |

 

 

 
| /s/   Dawn L. Farrell                 |   |
|---------------------------------------|--------|
|                                  |
| Dawn L. Farrell                       |
| President and Chief Executive Officer |
|                                  |
| Dated:  October   30, 2012.      |

 

 

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

----
### **[Subchapter Y—Repealed]**
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 5314 Introduced in Senate (IS)]

<DOC>

117th CONGRESS
  2d Session
                                S. 5314

 To improve the operation of the Organ Procurement and Transplantation 
                                Network.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           December 20, 2022

 Mr. Young (for himself and Mr. Cardin) introduced the following bill; 
     which was read twice and referred to the Committee on Health, 
                     Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL

 
 To improve the operation of the Organ Procurement and Transplantation 
                                Network.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Lost Opportunities to Supply 
Transplantable Organs Act of 2022'' or the ``LOST Organs Act of 2022''.

SEC. 2. ORGAN PROCUREMENT AND TRANSPLANTATION NETWORK.

    Section 372(b)(2) of the Public Health Service Act (42 U.S.C. 
274(b)(2)) is amended--
            (1) in subparagraph (E), by inserting ``and practice'' 
        after ``quality'';
            (2) by moving subparagraphs (M) through (O) 2 ems to the 
        left;
            (3) by redesignating subparagraphs (H) through (O) as 
        subparagraphs (J) through (Q), respectively; and
            (4) by inserting after subparagraph (G) the following:
            ``(H) track and publicly report, with redactions of 
        personal identifiers of donors, waitlist candidates, and 
        recipients, on the status of all organs in transport from organ 
        procurement organizations to any location within the transplant 
        supply chain, including transplant centers,
            ``(I) in the event that an organ is lost, damaged, or 
        delayed in transport, establish an open and transparent process 
        to determine cause, corrective action, and recommendations for 
        updates to the standards of quality and practice under 
        subparagraph (E) to prevent organs from being lost, damaged, or 
        delayed,''.
                                 <all>
```
### [§1002. Repealed. Pub. L. 94–455, title XIX, §1901(b)(28)(B)(i), Oct. 4, 1976, 90 Stat. 1799]

Section, act Aug. 16, 1954, ch. 736, 68A Stat. 295, related to the recognition of the entire amount of gain or loss determined under section 1001 on the sale or exchange of property.

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date of Repeal

Repeal effective for taxable years beginning after Dec. 31, 1976, see section 1901(d) of Pub. L. 94–455, set out as an Effective Date of 1976 Amendment note under section 2 of this title.
### §961. Office expenses of clerks

Each clerk of court shall be allowed his necessary office expenses when authorized by the Director of the Administrative Office of the United States Courts.

(June 25, 1948, ch. 646, 62 Stat. 927.)

#### Historical and Revision Notes

Based on title 28, U.S.C., 1940 ed., §§544, 563 (Mar. 3, 1891, ch. 517, §2, 26 Stat. 826; Feb. 26, 1919, ch. 49, §5, 40 Stat. 1182; Mar. 4, 1921, ch. 161, §1, 41 Stat. 1412; June 1, 1922, ch. 204, title II, 42 Stat. 616; May 17, 1932, ch. 190, 47 Stat. 158; June 25, 1936, ch. 804, 49 Stat. 1921).

Section consolidates parts of sections 544 and 563 of title 28, U.S.C., 1940 ed. For remainder of such sections, see Distribution Table.

Changes were made in phraseology.
April 2, 2004 

Mr. Clayton Bradt, C.H.P. 

Associate Radiophysicist 

Radiological Health Unit 

Division of Safety and Health 

New York State Department of Labor 

NYS Office Campus, Building 12, Room 169 

Albany, NY 12240 

Dear Mr. Bradt: 
April 2, 2004 

Mr. Clayton Bradt, C.H.P., Associate Radiophysicist

Radiological Health Unit

Division of Safety and Health 

New York State Department of Labor

NYS Office Campus, Building 12, Room 169

Albany, NY 12240

Dear Mr. Bradt: 

We have reviewed the New York State Department of Labor (NYDOL) license conditions that 

were submitted to meet the Generally Licenced Device (GL) reporting requirements of 10 CFR 

32.52 (a) and (b). Our review and comments are in response to the State’s request for Nuclear 

Regulatory Commission (NRC) evaluation of the license conditions that incorporated the 

NRC Chronology Identification FR Notice (Date Due For State Implem entation) RATS ID Proposed (P) / Final (F) 1 Rule / ML # 5 NRC Rev iew / Y, N 2 / Date /ML # 5 Final State Regulation 1 (Effectiv e Date) Timeliness in Decommissioning Material F acilities- Parts31,40,8 0 59 F R36026 (8/15/97) 1994-3 F-N 1/28/00 4/15/99 Preparation, T ransfer for Commerc Tf
#### In the Matter of the Accounting of Frank C. Genovese, as Executor of Marguerite J. Mlette, Deceased, Appellant. Joseph C. Genovese, Attorney for *971Executor, Appellant; John Bolinger et al., Respondents.

Decree and order of the Surrogate’s Court, Putnam County, insofar as appealed from, unanimously affirmed, with costs to the successful parties who have appeared and filed briefs, payable out of the estate. No opinion. Present — Lewis, P. J., Johnston, Adel, Sneed and Wenzel, JJ, [See *ante,*p. 740; *post,*p. 985.]
Exhibit
      32.2





CERTIFICATION
      PURSUANT TO


18
      U.S.C.
      SECTION 1350,


AS
      ADOPTED PURSUANT TO


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002





In
      connection with the Annual report of Fellows Energy Ltd. (the “Company”) on Form
      10-KSB for the period ending December 31, 2006 as filed with the Securities
      and
      Exchange Commission on the date hereof (the “Report”), I, George S. Young,
      Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C.
      section 906 of the Sarbanes-Oxley Act of 2002, that:





(1)
            The
                Report fully complies with the requirements of section 13(a) or 15(d)
                of
                the Securities and Exchange Act of 1934;
                and





(2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and result of operations of the
                Company.





A
      signed original of this written
      statement required by Section 906 has been provided to Fellows Energy Ltd.
      and
      will be retained by Fellows Energy Ltd. and furnished to the Securities and
      Exchange Commission or its staff upon request.





Date:  April
                20, 2007
            By:*/s/ GEORGE S. YOUNG*George
                S. YoungPrincipal
                Financial Officer
<PAGE>   1





EXHIBIT 11

ENTREMED, INC.

COMPUTATION OF EARNINGS PER SHARE (1)

<TABLE>
<CAPTION>
                                                              Three Months Ended                      Nine Months Ended
                                                                  September 30,                          September 30,
                                                     1996                             1995        1996                    1995
                                                   ---------------------------------------------------------------------------
<S>                                                 <C>                      <C>                 <C>              <C>
Weighted average common and common                                         
equivalent shares outstanding during the period           11,993,912             5,463,575          8,710,439         5,315,435
                                                                           
Effect of common stock issued and stock options                            
and warrants granted subsequent to April 12, 1995                          
computed in accordance with the treasury stock                             
method as required by the SEC (2)                                  -             1,933,236            283,775         1,812,689
                                                                                                                               
                                                    ---------------------------------------------------------------------------
Total common and common equivalent shares                 11,993,912             7,396,811          8,994,214         7,128,124
                                                    ===========================================================================
                                                                           
Net loss                                            $     (1,379,087)         $ (1,582,545)      $ (3,519,432)     $ (5,132,926)
                                                    ===========================================================================
                                                                           
Net loss per share                                  $          (0.11)         $      (0.21)      $      (0.39)     $      (0.72)
                                                    ---------------------------------------------------------------------------
</TABLE>

(1)  All share information has been adjusted to reflect a two-for-three reverse
stock split.

(2)  Pursuant to Securities and Exchange Commission Staff Accounting Bulletin
No. 83, Common and Preferred Stock issued and stock options and warrants 
granted at prices below the initial public offering price of $ 15.00 per share
during the 12-month period immediately preceding the initial filing date of the
Company's Registration Statement for its initial public offering have been
included as outstanding for all periods presented using the treasury stock
method.
EXHIBIT 31.1 CERTIFICATION  I, Keith Berman, Principal Executive and Chief Financial Officer of instaCare Corp., certify that:  1. I have reviewed this Annual Report on Form 10-K of InstaCare Corp.;  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;  4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;  c. Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and  d. Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and  5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrants auditors of the registrants board of directors (or persons performing the equivalent functions):  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.  Date: October 7, 2008  /s/ Keith Berman Keith Berman Chief Financial Officer and Principal Executive Officer
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
LEVIATHAN GAS PIPELINE PARTNERS, L.P. AND SUBSIDIARIES CONSOLIDATED
FINANCIAL STATEMENTS AT SEPTEMBER 30, 1997 INCLUDED IN ITS FORM 10-Q FOR
THE PERIOD ENDED SEPTEMBER 30, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FORM 10-Q.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               SEP-30-1997
<EXCHANGE-RATE>                                      1
<CASH>                                           2,345
<SECURITIES>                                         0
<RECEIVABLES>                                   11,177
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                14,392
<PP&E>                                         277,868
<DEPRECIATION>                                  90,530
<TOTAL-ASSETS>                                 395,738
<CURRENT-LIABILITIES>                            9,258
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                     154,925
<TOTAL-LIABILITY-AND-EQUITY>                   395,738
<SALES>                                         49,125
<TOTAL-REVENUES>                                84,728
<CGS>                                            8,674
<TOTAL-COSTS>                                    8,674
<OTHER-EXPENSES>                                60,696
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              10,350
<INCOME-PRETAX>                                (3,855)
<INCOME-TAX>                                     (238)
<INCOME-CONTINUING>                            (3,617)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (3,617)
<EPS-PRIMARY>                                   (0.15)
<EPS-DILUTED>                                   (0.15)
        

</TABLE>
#### Frank Spinetta et al., Respondents, v. Orlando Capobianco, Appellant.

Present — Cars-well, Acting P. J., Johnston, Adel, Sneed and MaeCrate, JJ. [See *ante,*p. 671.]
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr.

, Chief Justice

Stephen J. Markman

Mary Beth Kelly

Brian K. Zahra

Bridget M. McCormack

David F. Viviano

Richard H. Bernstein

, Justices

I, Larry S. Royster , Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

September 1, 2015 

# Order

Clerk September 1 , 2015

149599 ( 10 4 )

BANK OF AMERICA, N

. A

. , Plaintiff

- Appellant,

SC: 149599

v COA: 307756

Oakland CC: 2010

- 112606

- CK

FIRST AMERICAN TITLE INSURANCE

COMPANY, PATRIOT TITLE AGENCY, KIRK

D. SCHIEB, WESTMINSTER ABSTRACT

COMPANY, WESTMINSTER TITLE AGENCY,

INC., PRIME FINANCIAL GROUP, INC.,

VALENTINO M. TRABUCCHI, PAMELA S.

NOTTURNO, f/k/a PAMELA S. SIIRA,

DOUG LAS K. SMITH, JOSHUA J. GRIGGS,

STATE VALUE APPRAISALS, LLC, NATHAN

B. HOGAN, and CHRISTINE D. MAYS,

Defendants

- Appellees,

and

FRED MATSON, MICHAEL LYNETT, JO KAY

JAMES, and PAUL SMITH,

Defendants.

_________________________________________/

On order of the C hief Justice

, the motion of plaintiff

- appellant for leave to file a

second supplemental authority letter is GRANTED. The second supplemental authority

letter submitted on August 24 , 2015, is accepted for filing.
HomeAbout NRCRadiation ProtectionHow the NRC Protects YouHealth Physics Positions Based on 10 CFR Part 20

# Health Physics Questions and Answers - Question 205

**Question 205:**
> 
(a) 10 CFR 20.1301 (a) (2) requires that the dose in any unrestricted area from external sources does not exceed 2 millirem "in any one hour." Since this is not an instantaneous limit, can the licensee operate at levels much higher than 2 millirem per hour for a very short period of time (e.g., 90 millirem /hr for 1 minute, then no dose for the rest of the hour)?

(b) If so, how is the 2 mrem in any one hour inspectable?

**Answer:**

General response: This requirement in 10 CFR 20.1301 (a) (2) is not new. It is essentially the same as the requirement in 10 CFR 20.105 (b) (1). Specific response:
> 
(a) Yes.

(b) The licensee must be able to demonstrate compliance with the dose limits of 10 CFR 20.1301 and the survey requirements of 10 CFR 20.1501. If an inspector identifies areas where the radiation levels may be in excess of 2 mrem in any one hour and the licensee is unable to demonstrate compliance with the dose limits for an unrestricted area and with the survey requirements, the licensee may be cited. 

(Reference: 10 CFR 20.1301, 10 CFR 20.1501)

Page Last Reviewed/Updated Wednesday, November 08, 2017
VP < 1.0E-6 torr at 25 C (E) BP > 400 C (E) H < 1.00E-8 (E) POTW removal (%) = 0-25 via biodeg Time for complete ultimate aerobic biodeg = wk Sorption to soils/sediments = low - moderate PBT Potential: P2B1 *CEB FATE: Migration to ground water = moderate - rapid

Health : Health Summary: Absorption is nil through the skin for the neat material, and poor through the skin for the material in solution, based on physical/chemical properties. Absorption is good through the lung and GI tract based on analogs. There is concern for irritaion to the eye, skin, and lung, based on information in the PMN MSDS. There also is possible concern for dermal and respiratory sensitization, based on analog test data ( : p ositive for dermal sensitzation in the mouse local lymph node assay).

Ecotox :
Test Organism Test Type Test End Point Predicted Measured Comments

fish 96-h LC50 15 daphnid 48-h LC50 1.4 green algal 96-h EC50 0.14 fish

_ chronic value 0.84 daphnid

_ chronic value 0.26

algal

_ chronic value 0.033

Sewage Sludge 3-h EC50

_ Sewage Sludge

_ Chronic Value _

Ecotox Values Comments: Predictions are based on SARs for zinc salts; SAR chemical class = ainc salt with Zn; MW 360; solid with mp unknown (P); p H7; effective concentrations based on 100% active ingredients and mean measured concentrations; hardness <150.0 mg/L as CaCO3; and TOC <2.0 mg/L;

Factors Values Comments Assessment Factor 10 Concentration of Concern ( p pb) 3

SARs zinc salts SAR Class zinc salt with Zn Ecotox Category N oneEcotox Factors Comments:

SAT Chair: J. Kwiat